You are currently browsing the archives for 19 January 2017.
Displaying 1 entry.

Acrux announced the results of an 8 month clinical study in the U.

Acrux announced the results of an 8 – month clinical study in the U.S. Carried out, it was shown that its Testosterone MD – Lotion applied to the armpit of men with low testosterone able to effectively and safely restore testosterone levels to the normal range without adverse side effects.

* Fast-drying, invisible sprays or liquids, a delivery platform with low or no skin irritation, superior cosmetic acceptability and simple, accurate and flexible dosing. The technology platform broad broad and well differentiated, issued patents.